TriSalus Life Sciences Inc. Revenue 2022–2025

Revenue Gross Profit Operating Income EBITDA Net Income EPS Shares Outstanding

TriSalus Life Sciences Inc. annual/quarterly revenue history and growth rate from 2022 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.

TriSalus Life Sciences Inc. revenue for the quarter ending March 31, 2026 was 8.9 M, a 2.92% decrease year-over-year.
TriSalus Life Sciences Inc. revenue for the twelve months ending March 31, 2026 was 40.8 M, a 54.93% increase year-over-year.
TriSalus Life Sciences Inc. annual revenue for 2025 was 45.2 M, a 53.41% increase from 2024.
TriSalus Life Sciences Inc. annual revenue for 2024 was 29.4 M, a 58.99% increase from 2023.
TriSalus Life Sciences Inc. annual revenue for 2023 was 18.5 M, a 49.31% increase from 2022.
TriSalus Life Sciences Inc. annual revenue for 2022 was 12.4 M.

Revenue

TRAILING 12 MONTHS · $B

QUARTERLY · $B

YEAR-OVER-YEAR GROWTH · %

TriSalus Life Sciences Inc. (TLSI) — Frequently Asked Questions

TriSalus Life Sciences Inc. (TLSI) is a publicly traded US company. It has a market capitalization of $135M. In fiscal 2025 it reported revenue of $45M and net income of -$39M. Explore TLSI's stock price, financial statements, earnings history, margins and key ratios below.

What is TriSalus Life Sciences Inc.'s market cap?

TriSalus Life Sciences Inc. (TLSI) has a market capitalization of $135M.

What is the TLSI stock price?

TLSI trades at $3.55 (+6.29% on the day).

How much revenue does TriSalus Life Sciences Inc. make?

TriSalus Life Sciences Inc. reported revenue of $45M in fiscal 2025.

Is TLSI profitable?

In fiscal 2025, TriSalus Life Sciences Inc. reported net income of -$39M.